Skip to content

Accelerate Retinal Disease Therapeutics with Virscio's Vascular Leakage Model

Virscio’s Expertise in VEGF-Induced Models Propels Retinal Vascular Research Forward

V-MK-23-0010-VEGF-Induced-Vascular-Leakage-Modeling

Discover the potential of Virscio’s VEGF-Induced Retinal Vascular Permeability model to hasten the development of therapeutics for retinal vascular diseases. With more than 20 years of experience, Virscio specializes in advanced preclinical models, methods, and technologies, aiming to enhance R&D efficiency and therapeutic innovation. Our approach combines collaborative engagement, unparalleled primate access, and scientific expertise to generate definitive data, thereby reducing development time, cost, and risk in diverse medical areas including ophthalmology.

In this overview, we delve into the application of Virscio’s VEGF-Induced Vascular Leakage Model in guiding retinal research. This model is pivotal for understanding and evaluating treatments targeting retinal vascular diseases, making it an essential component of preclinical ophthalmic research.

Explore how Virscio's VEGF-Induced Retinal Vascular Leakage model can be instrumental in your retinal disease research, providing critical insights into the efficacy and safety of potential treatments.

DOWNLOAD FILE

Discover Our Vascular Leakage Model Now!

Explore how Virscio's VEGF-Induced Retinal Vascular Leakage model can be instrumental in your retinal disease research, providing critical insights into the efficacy and safety of potential treatments.

Virscio's commitment to de-risking innovation is exemplified by our broad scientific and technical expertise across various preclinical disciplines, including ophthalmic disease models. We provide comprehensive services from initial study design to execution and reporting​​.

In this overview of our VEGF-Induced Retinal Vascular Leakage Model, you will learn about:

  • The experimental design and application of the model in evaluating new treatments for retinal vascular diseases.
  • The use of fluorescein angiogram imaging to assess retinal vascular pathology and vascular permeability post-VEGF injections.
  • The effectiveness of therapeutics like Lucentis in preventing retinal vascular pathology and permeability compared to control treatments.

Connect with Our Experts: Schedule a Consultation Today!

Contact Virscio today to learn how our VEGF-Induced Vascular Leakage Model can support your research endeavors and accelerate the development of effective retinal disease treatments.
Schedule a Consultation Today!